Marathon Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Marathon Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$447K	Hold	2,650	–	–	0.1%	112
2025 Q4	$447K	Sell	2,650 -165	-6%	-$26.8K	0.1%	114
2025 Q3	$406K	Sell	2,815 -500	-15%	-$68.3K	0.09%	109
2025 Q2	$419K	Sell	3,315 -300	-8%	-$36.8K	0.11%	107
2025 Q1	$462K	Hold	3,615	–	–	0.12%	98
2024 Q4	$478K	Hold	3,615	–	–	0.12%	96
2024 Q3	$526K	Hold	3,615	–	–	0.13%	92
2024 Q2	$496K	Hold	3,615	–	–	0.13%	92
2024 Q1	$496K	Hold	3,615	–	–	0.12%	94
2023 Q4	$491K	Hold	3,615	–	–	0.12%	97
2023 Q3	$442K	Sell	3,615 -200	-5%	-$25.4K	0.11%	96
2023 Q2	$484K	Sell	3,815 -100	-3%	-$13K	0.12%	96
2023 Q1	$506K	Sell	3,915 -200	-5%	-$26.2K	0.12%	98
2022 Q4	$540K	Buy	4,115 +100	+2%	+$12.9K	0.15%	89
2022 Q3	$470K	Buy	+4,015	New	+$499K	0.13%	98
2022 Q1	–	Sell	-3,715	Closed	-$567K	–	127
2021 Q4	$567K	Sell	3,715 -600	-14%	-$92.9K	0.13%	99
2021 Q3	$698K	Sell	4,315 -500	-10%	-$84.1K	0.16%	89
2021 Q2	$787K	Hold	4,815	–	–	0.18%	72
2021 Q1	$724K	Hold	4,815	–	–	0.19%	67
2020 Q4	$729K	Sell	4,815 -100	-2%	-$14.3K	0.21%	65
2020 Q3	$665K	Hold	4,915	–	–	0.24%	64
2020 Q2	$672K	Buy	+4,915	New	+$627K	0.26%	56

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Marathon Capital Management's IBB Position: Q1 2026 in Review

Marathon Capital Management held its iShares Biotechnology ETF (IBB) position steady in Q1 2026 at 2,650 shares worth $447K. The position accounts for 0.1% of the portfolio, ranked #112.

Marathon Capital Management first reported a position in IBB in Q2 2020 and has held it in 22 quarters since. The position peaked at $787K in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

Marathon Capital Management held 2,650 shares of iShares Biotechnology ETF worth $447K as of Q1 2026.
Marathon Capital Management left its iShares Biotechnology ETF share count unchanged in Q1 2026.
iShares Biotechnology ETF made up 0.1% of Marathon Capital Management's portfolio in Q1 2026, its #112 holding.
Marathon Capital Management first reported a position in iShares Biotechnology ETF in Q2 2020 and has held it in 22 quarters since.
Marathon Capital Management's iShares Biotechnology ETF position peaked at $787K in Q2 2021.
917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Marathon Capital Management's 13F filing for Q1 2026, filed 14 May 2026.